Production (Stage)
Kronos Bio, Inc.
KRON
$0.8748
$0.00280.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.49M | -86.08M | -85.59M | -102.85M | -116.39M |
| Total Depreciation and Amortization | 1.46M | 1.72M | 1.79M | 1.88M | 2.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.85M | 36.82M | 24.10M | 27.71M | 34.11M |
| Change in Net Operating Assets | -17.21M | -17.89M | -17.92M | -14.58M | -16.29M |
| Cash from Operations | -54.38M | -65.44M | -77.62M | -87.84M | -96.53M |
| Capital Expenditure | 3.00K | -4.00K | -31.00K | -252.00K | -560.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 99.51M | 85.44M | 94.67M | 113.55M | 79.05M |
| Cash from Investing | 99.51M | 85.44M | 94.64M | 113.30M | 78.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 246.00K | 246.00K | 355.00K | 355.00K | 567.00K |
| Repurchase of Common Stock | -1.00K | -1.00K | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 245.00K | 245.00K | 354.00K | 355.00K | 567.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.38M | 20.25M | 17.37M | 25.81M | -17.47M |